Cellular prion protein neuroprotective function: implications in prion diseases (original) (raw)

References

  1. Basler K, Oesch B, Scott M, Westaway D, Walchli M, Groth DF, McKinley MP, Prusiner SB, Weissmann C (1986) Scrapie and cellular PrP isoforms are encoded by the same chromosomal gene. Cell 46:417–428
    CAS PubMed Google Scholar
  2. Kretzschmar HA, Prusiner SB, Stowring LE, DeArmond SJ (1986) Scrapie prion proteins are synthesized in neurons. Am J Pathol 122:1–5
    CAS PubMed Google Scholar
  3. Moudjou M, Frobert Y, Grassi J, La Bonnardiere C (2001) Cellular prion protein status in sheep: tissue-specific biochemical signatures. J Gen Virol 82:2017–2024
    CAS PubMed Google Scholar
  4. Prusiner SB (1982) Novel proteinaceous infectious particles cause scrapie. Science 216:136–144
    CAS PubMed Google Scholar
  5. Bueler H, Aguzzi A, Sailer A, Greiner RA, Autenried P, Aguet M, Weissmann C (1993) Mice devoid of PrP are resistant to scrapie. Cell 73:1339–1347
    Article CAS PubMed Google Scholar
  6. Prusiner SB, Groth D, Serban A, Koehler R, Foster D, Torchia M, Burton D, Yang SL, DeArmond SJ (1993) Ablation of the prion protein (PrP) gene in mice prevents scrapie and facilitates production of anti-PrP antibodies. Proc Natl Acad Sci USA 90:10608–10612
    CAS PubMed Google Scholar
  7. Sailer A, Bueler H, Fischer M, Aguzzi A, Weissmann C (1994) No propagation of prions in mice devoid of PrP. Cell 77:967–968
    CAS PubMed Google Scholar
  8. Weissmann C, Flechsig E (2003) PrP knock-out and PrP transgenic mice in prion research. Br Med Bull 66:43–60
    CAS PubMed Google Scholar
  9. Manson JC, Clarke AR, Hooper ML, Aitchison L, McConnell I, Hope J (1994) 129/Ola mice carrying a null mutation in PrP that abolishes mRNA production are developmentally normal. Mol Neurobiol 8:121–127
    CAS PubMed Google Scholar
  10. Nishida N, Tremblay P, Sugimoto T, Shigematsu K, Shirabe S, Petromilli C, Erpel SP, Nakaoke R, Atarashi R, Houtani T, Torchia M, Sakaguchi S, DeArmond SJ, Prusiner SB, Katamine S (1999) A mouse prion protein transgene rescues mice deficient for the prion protein gene from purkinje cell degeneration and demyelination. Lab Invest 79:689–697
    CAS PubMed Google Scholar
  11. Rossi D, Cozzio A, Flechsig E, Klein MA, Rulicke T, Aguzzi A, Weissmann C (2001) Onset of ataxia and Purkinje cell loss in PrP null mice inversely correlated with Dpl level in brain. EMBO J 20:694–702
    CAS PubMed Google Scholar
  12. Sakaguchi S, Katamine S, Nishida N, Moriuchi R, Shigematsu K, Sugimoto T, Nakatani A, Kataoka Y, Houtani T, Shirabe S, Okada H, Hasegawa S, Miyamoto T, Noda T (1996) Loss of cerebellar Purkinje cells in aged mice homozygous for a disrupted PrP gene. Nature 380:528–531
    CAS PubMed Google Scholar
  13. Moore RC, Lee IY, Silverman GL, Harrison PM, Strome R, Heinrich C, Karunaratne A, Pasternak SH, Chishti MA, Liang Y, Mastrangelo P, Wang K, Smit AF, Katamine S, Carlson GA, Cohen FE, Prusiner SB, Melton DW, Tremblay P, Hood LE, Westaway D (1999) Ataxia in prion protein (PrP)-deficient mice is associated with upregulation of the novel PrP-like protein doppel. J Mol Biol 292:797–817
    CAS PubMed Google Scholar
  14. Anderson L, Rossi D, Linehan J, Brandner S, Weissmann C (2004) Transgene-driven expression of the Doppel protein in Purkinje cells causes Purkinje cell degeneration and motor impairment. Proc Natl Acad Sci USA 101:3644–3649
    CAS PubMed Google Scholar
  15. Genoud N, Behrens A, Miele G, Robay D, Heppner FL, Freigang S, Aguzzi A (2004) Disruption of Doppel prevents neurodegeneration in mice with extensive Prnp deletions. Proc Natl Acad Sci USA 101:4198–4203
    Article CAS PubMed Google Scholar
  16. Kuwahara C, Takeuchi A, Nishimura T, Haraguchi K, Kubosaki A, Matsumoto Y, Saeki K, Matsumoto Y, Yokoyama T, Itohara S, Onodera T (1999) Prions prevent neuronal cell-line death. Nature 400:225–226
    Article CAS PubMed Google Scholar
  17. Kim BH, Lee HG, Choi JK, Kim JI, Choi EK, Carp RI, Kim YS (2004) The cellular prion protein (PrP (C)) prevents apoptotic neuronal cell death and mitochondrial dysfunction induced by serum deprivation. Brain Res Mol Brain Res 124:40–50
    CAS PubMed Google Scholar
  18. Brown DR, Schulz-Schaeffer WJ, Schmidt B, Kretzschmar HA (1997) Prion protein-deficient cells show altered response to oxidative stress due to decreased SOD-1 activity. Exp Neurol 146:104–112
    Article CAS PubMed Google Scholar
  19. Brown DR, Nicholas RS, Canevari L (2002) Lack of prion protein expression results in a neuronal phenotype sensitive to stress. J Neurosci Res 67:211–224
    Article CAS PubMed Google Scholar
  20. White AR, Collins SJ, Maher F, Jobling MF, Stewart LR, Thyer JM, Beyreuther K, Masters CL, Cappai R (1999) Prion protein-deficient neurons reveal lower glutathione reductase activity and increased susceptibility to hydrogen peroxide toxicity. Am J Pathol 155:1723–1730
    CAS PubMed Google Scholar
  21. Wong BS, Liu T, Li R, Pan T, Petersen RB, Smith MA, Gambetti P, Perry G, Manson JC, BrownDR, Sy MS (2001) Increased levels of oxidative stress markers detected in the brains of mice devoid of prion protein. J Neurochem 76:565–572
    Article CAS PubMed Google Scholar
  22. Klamt F, Dal-Pizzol F, Conte da Frota MJ, Walz R, Andrades ME, da Silva EG, Brentani RR, Izquierdo I, Fonseca Moreira JC (2001) Imbalance of antioxidant defense in mice lacking cellular prion protein. Free Radic Biol Med 30:1137–1144
    Article CAS PubMed Google Scholar
  23. Vassallo N, J Herms (2003) Cellular prion protein function in copper homeostasis and redox signalling at the synapse. J Neurochem 86:538–544
    Article CAS PubMed Google Scholar
  24. Brown DR, Wong BS, Hafiz F, Clive C, Haswell SJ, Jones IM (1999) Normal prion protein has an activity like that of superoxide dismutase. Biochem J 344:1–5
    Article CAS PubMed Google Scholar
  25. Wong BS, Pan T, Liu T, Li R, Gambetti P, Sy MS (2000) Differential contribution of superoxide dismutase activity by prion protein in vivo. Biochem Biophys Res Commun 273:136–139
    Article CAS PubMed Google Scholar
  26. Hutter G, Heppner FL, Aguzzi A (2003) No superoxide dismutase activity of cellular prion protein in vivo. Biol Chem 384:1279–1285
    Article CAS PubMed Google Scholar
  27. Sakudo A, Lee DC, Saeki K, Nakamura Y, Inoue K, Matsumoto Y, Itohara S, Onodera T (2003) Impairment of superoxide dismutase activation by N-terminally truncated prion protein (PrP) in PrP-deficient neuronal cell line. Biochem Biophys Res Commun 308:660–667
    Article CAS PubMed Google Scholar
  28. Nakamura Y, Sakudo A, Saeki K, Kaneko T, Matsumoto Y, Toniolo A, Itohara S, Onodera T (2003) Transfection of prion protein gene suppresses coxsackievirus B3 replication in prion protein gene-deficient cells. J Gen Virol 84:3495–3502
    Article CAS PubMed Google Scholar
  29. Grossman A, Zeiler B, Sapirstein V (2003) Prion protein interactions with nucleic acid: possible models for prion disease and prion function. Neurochem Res 28:955–963
    Article CAS PubMed Google Scholar
  30. Leblanc P, Baas D, Darlix JL (2004) Analysis of the interactions between HIV-1 and the cellular prion protein in a human cell line. J Mol Biol 337:1035–1051
    Article CAS PubMed Google Scholar
  31. LeBlanc A (1998) Unravelling the controversy of prion diseases. In: Wang SSAE (ed) Handbook of the aging brain. Academic, New York, pp 202–214
  32. Yin X-M, Oltvai ZN, Korsmeyer SJ (1994) BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature 369:321–323
    Article CAS PubMed Google Scholar
  33. Kurschner C, Morgan J (1995) The cellular prion protein (PrP) selectively binds to Bcl-2 in the yeast two-hybrid sustem. Brain Res Mol Brain Res 30:165–168
    CAS PubMed Google Scholar
  34. Kurschner C, Morgan J (1996) Analysis of interaction sites in homo- and heteromeric complexes containing Bcl-2 family members and the cellular prion protein. Brain Res Mol Brain Res 37:249–258
    CAS PubMed Google Scholar
  35. Bounhar Y, Zhang Y, Goodyer C, LeBlanc A (2001) Prion protein protects against Bax-mediated cell death. J Biol Chem 276:39145–39149
    Article CAS PubMed Google Scholar
  36. Medori R, Tritschler H, LeBlanc A, Villare F, Manetto V, Chen H, Xue R, Montagna P, Cortelli P, Tinuper P, Avoni P, Mochi M, Baruzzi A, Hauw J, Lugaresi E, Autilio-Gambetti L, Gambetti P (1992) Fatal familial insomnia is a prion disease with a mutation at codon 178 of the prion protein gene. N Engl J Med 326:444–449
    CAS PubMed Google Scholar
  37. Nitrini R, Rosemberg S, Passos-Bueno MR, Lughetti P, Papadopoulos M, Carrilho PE, Caramelli P, Albrecht S, Zatz M, LeBlanc AC (1997) Familial Spongiform Encephalopathy with distinct clinico-pathological features associated with a novel prion protein gene mutation at codon 183. Ann Neurol 42:138–146
    CAS PubMed Google Scholar
  38. Roucou X, Guo G, Zhang Y, Goodyer CG, LeBlanc AC (2003) Cytosolic prion protein is not toxic and protects against Bax-mediated cell death in human primary neurons. J Biol Chem 278:40877–40881
    Article CAS PubMed Google Scholar
  39. Deckwerth TL, Elliott JL, Knudson CM, Johnson Jr EM, Snider WD, Korsmeyer SJ (1996) BAX is required for neuronal death after trophic factor deprivation and during development. Neuron 17:401–411
    Article CAS PubMed Google Scholar
  40. Diarra-Mehrpour M, Arrabal S, Jalil A, Pinson X, Gaudin C, Pietu G, Pitaval A, Ripoche H, Eloit M, Dormont D, Chouaib S (2004) Prion protein prevents human breast carcinoma cell line from tumor necrosis factor alpha-induced cell death. Cancer Res 64:719–727
    CAS PubMed Google Scholar
  41. Roucou X, Gains M, LeBlanc AC (2004) Neuroprotective functions of prion protein. J Neurosci Res 75:153–161
    Article CAS PubMed Google Scholar
  42. Schneider B, Mutel V, Pietri M, Ermonval M, Mouillet-Richard S, Kellermann O (2003) NADPH oxidase and extracellular regulated kinases 1/2 are targets of prion protein signaling in neuronal and nonneuronal cells. Proc Natl Acad Sci USA 100:13326–13331
    CAS PubMed Google Scholar
  43. Grewal SS, York RD, Stork PJ (1999) Extracellular-signal-regulated kinase signalling in neurons. Curr Opin Neurobiol 9:544–553
    Article CAS PubMed Google Scholar
  44. Mouillet-Richard S, Ermonval M, Chebassier C, Laplanche JL, Lehmann S, Launay JM, Kellermann O (2000) Signal transduction through prion protein. Science 289:1925–1928
    Article CAS PubMed Google Scholar
  45. Chiarini LB, Freitas AR, Zanata SM, Brentani RR, Martins VR, Linden R (2002) Cellular prion protein transduces neuroprotective signals. EMBO J 21:3317–3326
    Article CAS PubMed Google Scholar
  46. Zanata SM, Lopes MH, Mercadante AF, Hajj GN, Chiarini LB, Nomizo R, Freitas AR, Cabral AL, Lee KS, Juliano MA, de Oliveira E, Jachieri SG, Burlingame A, Huang L, Linden R, Brentani RR, Martins VR (2002) Stress-inducible protein 1 is a cell surface ligand for cellular prion that triggers neuroprotection. EMBO J 21:3307–3316
    CAS PubMed Google Scholar
  47. Chen S, Mange A, Dong L, Lehmann S, Schachner M (2003) Prion protein as trans-interacting partner for neurons is involved in neurite outgrowth and neuronal survival. Mol Cell Neurosci 22:227–233
    CAS PubMed Google Scholar
  48. Graner E, Mercadante AF, Zanata SM, Forlenza OV, Cabral AL, Veiga SS, Juliano MA, Roesler R, Walz R, Minetti A, Izquierdo I, Martins VR, Brentani RR (2000) Cellular prion protein binds laminin and mediates neuritogenesis. Brain Res Mol Brain Res 76:85–92
    CAS PubMed Google Scholar
  49. Gauczynski S, Peyrin JM, Haik S, Leucht C, Hundt C, Rieger R, Krasemann S, Deslys JP, Dormont D, Lasmezas CI, Weiss S (2001) The 37-kDa/67-kDa laminin receptor acts as the cell-surface receptor for the cellular prion protein. EMBO J 20:5863–5875
    Article CAS PubMed Google Scholar
  50. Schmitt-Ulms G, Legname G, Baldwin MA, Ball HL, Bradon N, Bosque PJ, Crossin KL, Edelman GM, DeArmond SJ, Cohen FE, Prusiner SB (2001) Binding of neural cell adhesion molecules (N-CAMs) to the cellular prion protein. J Mol Biol 314:1209–1225
    Article CAS PubMed Google Scholar
  51. Spielhaupter C, Schatzl HM (2001) PrPC directly interacts with proteins involved in signaling pathways. J Biol Chem 276:44604–44612
    Article CAS PubMed Google Scholar
  52. Liu T, Li R, Pan T, Liu D, Petersen RB, Wong BS, Gambetti P, Sy MS (2002) Intercellular transfer of the cellular prion protein. J Biol Chem 277:47671–47678
    Article CAS PubMed Google Scholar
  53. Kooyman DL, Byrne GW, Logan JS (1998) Glycosyl phosphatidylinositol anchor. Exp Nephrol 6:148–151
    Article CAS PubMed Google Scholar
  54. Yin XM (2000) Signal transduction mediated by Bid, a pro-death Bcl-2 family proteins, connects the death receptor and mitochondria apoptosis pathways. Cell Res 10:161–167
    CAS PubMed Google Scholar
  55. Martinou JC, Green DR (2001) Breaking the mitochondrial barrier. Nat Rev Mol Cell Biol 2:63–67
    Article CAS PubMed Google Scholar
  56. Schinzel A, Kaufmann T, Schuler M, Martinalbo J, Grubb D, Borner C (2004) Conformational control of Bax localization and apoptotic activity by Pro168. J Cell Biol 164:1021–1032
    Article CAS PubMed Google Scholar
  57. Atarashi R, Nishida N, Shigematsu K, Goto S, Kondo T, Sakaguchi S, Katamine S (2003) Deletion of N-terminal residues 23–88 from prion protein (PrP) abrogates the potential to rescue PrP-deficient mice from PrP-like protein/Doppel-induced neurodegeneration. J Biol Chem 278:28944–28949
    Article CAS PubMed Google Scholar
  58. Behrens A, Aguzzi A (2002) Small is not beautiful: antagonizing functions for the prion protein PrP (C) and its homologue Dpl. Trends Neurosci 25:150–154
    Article CAS PubMed Google Scholar
  59. Wong BS, Liu T, Paisley D, Li R, Pan T, Chen SG, Perry G, Petersen RB, Smith MA, Melton DW, Gambetti P, Brown DR, Sy MS (2001) Induction of HO-1 and NOS in doppel-expressing mice devoid of PrP: implications for doppel function. Mol Cell Neurosci 17:768–775
    Article CAS PubMed Google Scholar
  60. Shmerling D, Hegyi I, Fischer M, Blattler T, Brandner S, Gotz J, Rulicke T, Flechsig E, Cozzio A, von Mering C, Hangartner C, Aguzzi A, Weissmann C (1998) Expression of amino-terminally truncated PrP in the mouse leading to ataxia and specific cerebellar lesions. Cell 93:203–214
    Article CAS PubMed Google Scholar
  61. Hoshino S, Inoue K, Yokoyama T, Kobayashi S, Asakura T, Teramoto A, Itohara S (2003) Prions prevent brain damage after experimental brain injury: a preliminary report. Acta Neurochir Suppl 86:297–299
    CAS PubMed Google Scholar
  62. Marciano PG, Brettschneider J, Manduchi E, Davis JE, Eastman S, Raghupathi R, Saatman KE, Speed TP, Stoeckert CJ Jr, Eberwine JH, McIntosh TK (2004) Neuron-specific mRNA complexity responses during hippocampal apoptosis after traumatic brain injury. J Neurosci 24:2866–2876
    Article CAS PubMed Google Scholar
  63. Shyu WC, Kao MC, Chou WY, Hsu YD, Soong BW (2000) Heat shock modulates prion protein expression in human NT-2 cells. Neuroreport 11:771–774
    CAS PubMed Google Scholar
  64. Walz R, Amaral OB, Rockenbach IC, Roesler R, Izquierdo I, Cavalheiro EA, Martins VR, Brentani RR (1999) Increased sensitivity to seizures in mice lacking cellular prion protein. Epilepsia 40:1679–1682
    CAS PubMed Google Scholar
  65. Chacon MA, Barria MI, Lorca R, Huidobro-Toro JP, Inestrosa NC (2003) A human prion protein peptide (PrP (59–91)) protects against copper neurotoxicity. Mol Psychiatry 8:853–862:835
    Google Scholar
  66. Paitel E, Alves da Costa C, Vilette D, Grassi J, Checler F (2002) Overexpression of PrPc triggers caspase 3 activation: potentiation by proteasome inhibitors and blockade by anti-PrP antibodies. J Neurochem 83:1208–1214
    Article CAS PubMed Google Scholar
  67. Paitel E, Fahraeus R, Checler F (2003) Cellular prion protein sensitizes neurons to apoptotic stimuli through Mdm2-regulated and p53-dependent caspase 3-like activation. J Biol Chem 278:10061–10066
    Article CAS PubMed Google Scholar
  68. Paitel E, Sunyach C, Alves da Costa C, Bourdon JC, Vincent B, Checler F (2004) Primary cultured neurons devoid of cellular prion display lower responsiveness to staurosporine through the control of p53 at both transcriptional and post-transcriptional levels. J Biol Chem 279:612–618
    Article CAS PubMed Google Scholar
  69. Hegde RS, Voigt S, Lingappa VR (1998) Regulation of protein topology by trans-acting factors at the endoplasmic reticulum. Mol Cell 2:85–91
    Article CAS PubMed Google Scholar
  70. Hegde RS, Mastrianni JA, Scott MR, DeFea KA, Tremblay P, Torchia M, DeArmond SJ, Prusiner SB, Lingappa VR (1998) A transmembrane form of the prion protein in neurodegenerative disease. Science 279:827–834
    Article CAS PubMed Google Scholar
  71. Ma J, Wollmann R, Lindquist S (2002) Neurotoxicity and neurodegeneration when PrP accumulates in the cytosol. Science 298:1781–1785
    Article CAS PubMed Google Scholar
  72. Ma J, Lindquist S (2001) Wild-type PrP and a mutant associated with prion disease are subject to retrograde transport and proteasome degradation. Proc Natl Acad Sci USA 98:14955–14960
    Article CAS PubMed Google Scholar
  73. Yedidia Y, Horonchik L, Tzaban S, Yanai A, Taraboulos A (2001) Proteasomes and ubiquitin are involved in the turnover of the wild-type prion protein. EMBO J 20:5383–5391
    CAS PubMed Google Scholar
  74. Drisaldi B, Stewart RS, Adles C, Stewart LR, Quaglio E, Biasini E, Fioriti L, Chiesa R, Harris DA (2003) Mutant PrP is delayed in its exit from the endoplasmic reticulum, but neither wild-type nor mutant PrP undergoes retrotranslocation prior to proteasomal degradation. J Biol Chem 278:21732–21743
    CAS PubMed Google Scholar
  75. Heller U, Winklhofer KF, Heske J, Reintjes A, Tatzelt J (2003) Post-translational import of the prion protein into the endoplasmic reticulum interferes with cell viability: a critical role for the putative transmembrane domain. J Biol Chem 278:36139–36147
    Article CAS PubMed Google Scholar
  76. Cheng EH, Kirsch DG, Clem RJ, Ravi R, Kastan MB, Bedi A, Ueno K, Hardwick JM (1997) Conversion of Bcl-2 to a Bax-like death effector by caspases. Science 278:1966–1968
    Article CAS PubMed Google Scholar
  77. Clem RJ, Cheng EH, Karp CL, Kirsch DG, Ueno K, Takahashi A, Kastan MB, Griffin DE, Earnshaw WC, Veliuona MA, Hardwick JM (1998) Modulation of cell death by Bcl-XL through caspase interaction. Proc Natl Acad Sci USA 95:554–559
    Article CAS PubMed Google Scholar
  78. Ghetti B, Piccardo P, Spillantini MG, Ichimiya Y, Porro M, Perini F, Kitamoto T, Tateishi J, Seiler C, Frangione B, Bugiani O, Giaccone G, Prelli F, Goedert M, Dlouhy SR, Tagliavini F (1996) Vascular variant of prion protein cerebral amyloidosis with tau-positive neurofibrillary tangles: the phenotype of the stop codon 145 mutation in PRNP. Proc Natl Acad Sci USA 93:744–748
    Article CAS PubMed Google Scholar
  79. Kitamoto T, Iizuka R, Tateishi J (1993) An amber mutation of prion protein in Gerstmann-Straussler syndrome with mutant PrP plaques. Biochem Biophys Res Commun 192:525–531
    Article CAS PubMed Google Scholar
  80. Solforosi L, Criado JR, McGavern DB, Wirz S, Sanchez-Alavez M, Sugama S, DeGiorgio LA, Volpe BT, Wiseman E, Abalos G, Masliah E, Gilden D, Oldstone MB, Conti B, Williamson RA (2004) Cross-linking cellular prion protein triggers neuronal apoptosis in vivo. Science 303:1514–1516
    Article CAS PubMed Google Scholar
  81. Meier P, Genoud N, Prinz M, Maissen M, Rulicke T, Zurbriggen A, Raeber AJ, Aguzzi A (2003) Soluble dimeric prion protein binds PrP (Sc) in vivo and antagonizes prion disease. Cell 113:49–60
    Article CAS PubMed Google Scholar
  82. Hegde R, Tremblay P, Groth D, DeArmond S, Prusiner S, Lingappa V (1999) Transmissible and genetic prion diseases share a common pathway of neurodegeneration. Nature 402:822–826
    Article CAS PubMed Google Scholar
  83. Ivanova L, Barmada S, Kummer T, Harris DA (2001) Mutant prion proteins are partially retained in the endoplasmic reticulum. J Biol Chem 276:42409–42421
    Article CAS PubMed Google Scholar
  84. Lorenz H, Windl O, Kretzschmar HA (2002) Cellular phenotyping of secretory and nuclear prion proteins associated with inherited prion diseases. J Biol Chem 277:8508–8516
    Article CAS PubMed Google Scholar
  85. Zanusso G, Petersen RB, Jin T, Jing Y, Kanoush R, Ferrari S, Gambetti P, Singh N (1999) Proteasomal degradation and N-terminal protease resistance of the codon 145 mutant prion protein. J Biol Chem 274:23396–23404
    Article CAS PubMed Google Scholar
  86. Merry DE, Veis DJ, Hickey WF, Korsmeyer SJ (1994) Bcl-2 protein expression is widespread in the developing nervous system and retained in the adult PNS. Development 120:301–311
    CAS PubMed Google Scholar
  87. Mallucci G, Dickinson A, Linehan J, Klohn PC, Brandner S, Collinge J (2003) Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis. Science 302:871–874
    Article CAS PubMed Google Scholar

Download references